BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/16/2020 7:58:40 AM | Browse: 53 | Download: 83
Publication Name World Journal of Gastroenterology
Manuscript ID 52065
Country of Manuscript Source Germany
2019-10-15 09:14
Peer-Review Started
2019-10-15 09:14
To Make the First Decision
Return for Revision
2019-12-04 20:13
2019-12-17 07:29
Second Decision
2019-12-30 05:43
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2020-01-01 23:14
Articles in Press
2020-01-01 23:14
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2020-01-14 00:59
Publish the Manuscript Online
2020-01-16 07:58
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology and Hepatology
Manuscript Type Minireviews
Article Title Fibroblast growth factor signaling in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Paving the way to hepatocellular carcinoma
Manuscript Source Invited Manuscript
All Author List Matthias Ocker
Author(s) ORCID Number
Matthias Ocker http://orcid.org/0000-0001-8263-6288
Funding Agency and Grant Number
Corresponding author Matthias Ocker, MD, Professor, Department of Gastroenterology, CBF, Charité University Medicine Berlin, Chariteplatz 1, Berlin 10117, Germany. matthiasocker@gmail.com
Keywords Fibroblast growth factor; Fibroblast growth factor receptor; Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Fibrosis; Cirrhosis
Core Tip Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis show globally rising incidences and are expected to become the main reason for liver fibrosis, cirrhosis, liver cancer and end-stage liver disease with need for transplantation. Liver metabolism is, among other factors, regulated by fibroblast growth factors and their receptors. This review highlights the role of these signaling pathways in the context of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis and discusses novel treatment options for these otherwise difficult to treat diseases.
Publish Date 2020-01-16 07:58
Citation Ocker M. Fibroblast growth factor signaling in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Paving the way to hepatocellular carcinoma. World J Gastroenterol 2020; 26(3): 279-290
Url https://www.wjgnet.com/1007-9327/full/v26/i3/279.htm
DOI https://dx.doi.org/10.3748/wjg.v26.i3.279
Full Article (PDF) WJG-26-279.pdf
Full Article (Word) WJG-26-279.docx
Manuscript File 52065-Review.docx
Answering Reviewers 52065-Answering reviewers.pdf
Audio Core Tip 52065-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 52065-Conflict-of-interest statement.pdf
Copyright License Agreement 52065-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate 52065-Language certificate.pdf
Peer-review Report 52065-Peer-review(s).pdf
Scientific Misconduct Check 52065-Scientific misconduct check.pdf
Scientific Editor Work List 52065-Scientific editor work list.pdf